-
Mashup Score: 1SCCT 2023 - 2 year(s) ago
Forgot Your Password? Enter the email you used to register to reset your password.
Source: www.tctmd.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
AI can yield more information from a CT image than just coronary narrowing. How it’s used and by whom remains to be seen.
Source: www.tctmd.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Guidelines take time to compile and even longer to sink in, but experts agree the advice can improve care if equitably applied.
Source: www.tctmd.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
Guidelines take time to compile and even longer to sink in, but experts agree the advice can improve care if equitably applied.
Source: www.tctmd.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
Out of more than 250 abstracts submitted at its annual meeting in Boston, SCCT named one winner and two runners-up.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
AI can yield more information from a CT image than just coronary narrowing. How it’s used and by whom remains to be seen.
Source: www.tctmd.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1
AI to help interpret cardiac CT was shown to reduce exam read times to improve workflow efficiency, and improve patient diagnostics with additional information on soft plaques. Data was presented in three HeartFlow AI technology studies at SCCT 2023.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 7
“We do have to generate the evidence for doing this and . . . the value-based argument for doing this,” Andrew Choi says.
Source: www.tctmd.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 5
An analysis of the PROMISE trial suggests such exposure should be considered an additional CV risk factor.
Source: www.tctmd.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 3
The U.S. Food and Drug Administration (FDA) is reclassifying interventional cardiovascular implant simulation software into the class II (special controls) regulatory category, which will make it easier for the technology to pass regulatory approval. The technology has grown rapidly over the last few years to better assess the fit and possible complications from device implants as part of the…
Source: Cardiovascular BusinessCategories: Cardiologists, Latest HeadlinesTweet
Presentations from #SCCT2023 are live on TCTMD! Don't miss these slides on cardiac CTs, structural valve disease, guideline assessments, and more: https://t.co/KjPWxRzz4h https://t.co/DhRy1t2dsY